Brade L, Kosma P, Appelmelk B J, Paulsen H, Brade H
Infect Immun. 1987 Feb;55(2):462-6. doi: 10.1128/iai.55.2.462-466.1987.
Mouse monoclonal antibodies were raised against heat-killed bacteria of the Re mutant R595 of Salmonella minnesota and characterized by the passive hemolysis and passive hemolysis inhibition tests and by double immunodiffusion experiments using lipopolysaccharide (LPS) from different rough mutants of S. minnesota and synthetic antigens. The latter were copolymerization products of acrylamide with the alpha- and beta-allylglycosides of 3-deoxy-D-manno-octulosonic acid (KDO) and the alpha-2,4-linked KDO disaccharide [poly-alpha-KDO, poly-beta-KDO, and poly-(alpha-KDO)2, respectively], and sodium (3-deoxy-D-manno-octulopyranosyl)onate-(2----6)-(2-deoxy-2-[ (R)-3- hydroxytetradecanoylamino]- beta-D-glucopyranosyl)-(1----6)-(2-deoxy-2-[(R)-3-hydroxytetradecanoy lam ino]-D-glucose) [alpha-KDO-(GlcNhm)2], representing a part structure of Re LPS. One antibody (clone 20, immunoglobulin M) was found to recognize a terminal alpha-linked KDO residue, since it reacted in the passive hemolysis assay with alpha-KDO-(GlcNhm)2 and all LPS tested, it was inhibited by all synthetic antigens containing alpha-linked KDO residues, and it gave a reaction of identity with poly-alpha-KDO and poly-(alpha-KDO)2 in double immunodiffusion experiments. A second antibody (clone 25, immunoglobulin G3) was identified as specific for an alpha-2,4-linked KDO disaccharide, since it reacted in immunodiffusion exclusively with synthetic poly-(alpha-KDO)2 and not with the monosaccharide derivatives in either anomeric configuration, and it was inhibited only with poly-(alpha-KDO)2 and with LPS from S. minnesota R595 (Re) and R345 (Rb2). The reaction of this antibody with R345 LPS is attributed to the quantitative substitution with KDO disaccharide present as a side chain, which is not present in stoichiometric amounts in the other LPS.
制备了针对明尼苏达沙门氏菌Re突变体R595热灭活细菌的小鼠单克隆抗体,并通过被动溶血和被动溶血抑制试验以及使用来自明尼苏达沙门氏菌不同粗糙突变体的脂多糖(LPS)和合成抗原的双向免疫扩散实验对其进行了表征。后者是丙烯酰胺与3-脱氧-D-甘露糖-辛酮糖酸(KDO)的α-和β-烯丙基糖苷以及α-2,4-连接的KDO二糖[分别为聚-α-KDO、聚-β-KDO和聚-(α-KDO)2]的共聚产物,以及(3-脱氧-D-甘露糖-辛吡喃糖基)酸钠-(2→6)-(2-脱氧-2-[(R)-3-羟基十四烷酰氨基]-β-D-吡喃葡萄糖基)-(1→6)-(2-脱氧-2-[(R)-3-羟基十四烷酰氨基]-D-葡萄糖)[α-KDO-(GlcNhm)2],代表Re LPS的部分结构。发现一种抗体(克隆20,免疫球蛋白M)识别末端α连接的KDO残基,因为它在被动溶血试验中与α-KDO-(GlcNhm)2和所有测试的LPS发生反应,它被所有含有α连接的KDO残基的合成抗原抑制,并且在双向免疫扩散实验中与聚-α-KDO和聚-(α-KDO)2产生同一性反应。第二种抗体(克隆25,免疫球蛋白G3)被鉴定为对α-2,4-连接的KDO二糖具有特异性,因为它在免疫扩散中仅与合成的聚-(α-KDO)2反应,而不与任何一种异头构型的单糖衍生物反应,并且仅被聚-(α-KDO)2以及来自明尼苏达沙门氏菌R595(Re)和R345(Rb2)的LPS抑制。该抗体与R345 LPS的反应归因于作为侧链存在的KDO二糖的定量取代,而在其他LPS中不存在化学计量的量。